In one year, ERI Scientific Beta has seen its assets under replication grow by 60%
ERI Scientific Beta, the smart beta index provider offshoot of EDHEC Risk Institute, has announced that assets tracking its smart beta indices had reached USD 16.46bn at June 30, 2017. In terms of geographical distribution, these assets come from North America (51%), Europe (46%) and Asia-Pacific (3%).
Compared to June 30, 2016, this amount of assets under replication represents growth of 60%.
An important driver of the growth in assets replicating Scientific Beta indices is live performance. The first generation Scientific Beta multi-smart-factor indices created in 2013 have a live track record for over 3 years that shows annualised outperformance of 2.20%1.
Commenting on the announcement Noël Amenc, CEO of ERI Scientific Beta, said, "Scientific Beta's success over the past four years is due in no small part to the fact that its investment philosophy has proven attractive to major institutional investors throughout the world. This investment philosophy is based on three major principles: the importance of controlling the risks of the investment, because the alternative choice to the cap-weighted index means that one takes different risks, and these risks must be controlled; the essential diversification of the specific risks of the benchmark to produce robust risk-adjusted performance and avoid good long-term investment ideas being called into question by poor short-term performance due to poor diversification; and the concern for robustness, which implies that the design of an index must rely on academic consensus and not on innovations drawn from optimising the returns or the in-sample characteristics of the strategy proposed."
1The average live outperformance across all Scientific Beta developed regions of Scientific Beta Multi-Beta Multi-Strategy (Equal Weight and Equal Risk Contribution) indices is 2.19% and 2.21%. This live analysis is based on daily total returns in the period from December 20, 2013 (live date) to June 30, 2017 for all diversified multi-strategy indices that have more than 3 years of track record for all available developed world regions - USA, Eurozone, UK, Developed Europe, Developed Europe ex UK, Japan, Developed Asia Pacific ex Japan, Developed ex UK, Developed ex USA and Developed. The benchmark used is a cap-weighted portfolio of all stocks in the respective Scientific Beta universes.
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #15-02, Singapore 049145. For further information, please contact: E-mail: [email protected], Web: www.scientificbeta.com.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/7daf51ee-dabb-46bc-b6b2-9c6c7f243891


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
Britain Courts Anthropic Amid US Defense Department Dispute
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 



